Masashi Bando
Overview
Explore the profile of Masashi Bando including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
137
Citations
3584
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arai T, Inoue Y, Akasaka K, Masunaga A, Fujita M, Yamaguchi E, et al.
Respir Investig
. 2024 Nov;
63(1):20-26.
PMID: 39615320
Background: The prognosis of patients with coronavirus disease 2019 (COVID-19) was poor although its survival rate has been improved after the occurrence of the Omicron strain. Autoimmune pulmonary alveolar proteinosis...
2.
Okamoto T, Hanafusa M, Abe T, Shimamura T, Ito M, Wakai Y, et al.
Allergol Int
. 2024 Nov;
74(1):66-71.
PMID: 39572336
Background: The latest guidelines on hypersensitivity pneumonitis (HP) categorise the disease as either fibrotic or non-fibrotic because of the greater clinical utility of this stratification. However, the prevalence and incidence...
3.
Kondoh Y, Furukawa T, Hozumi H, Suda T, Egashira R, Jokoh T, et al.
BMC Pulm Med
. 2024 Oct;
24(1):511.
PMID: 39396941
Background: Multidisciplinary discussion (MDD), in which physicians, radiologists, and pathologists communicate and diagnose together, has been reported to improve diagnostic accuracy compared to diagnoses made solely by physicians. However, even...
4.
Arai N, Takasaki T, Bando M, Yaoita K, Ueki Y, Hisata S, et al.
Respir Med Case Rep
. 2024 Sep;
51:102103.
PMID: 39286411
Anti-neutrophil cytoplasmic antibody-associated vasculitis is triggered by infection, dust exposure, and drugs. A 73-year-old male presented with dyspnea. Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection was confirmed upon admission. Exacerbation...
5.
Kurosaki F, Takigami A, Takeuchi M, Shimizu A, Tamba K, Bando M, et al.
BMC Palliat Care
. 2024 Aug;
23(1):216.
PMID: 39198855
Background: Central pain, characterized by neuropathic pain, can manifest due to injury to the superior spinothalamic tract. The brainstem includes sensory and motor pathways as well as nuclei of the...
6.
Bando M, Chiba H, Miyazaki Y, Suda T
Respir Investig
. 2024 Jul;
62(5):785-793.
PMID: 38996779
Idiopathic pulmonary fibrosis (IPF) is the archetypal interstitial lung disease. It is a chronic progressive condition that is challenging to manage as the clinical course of the disease is often...
7.
Kondoh Y, Bando M, Kawahito Y, Sato S, Suda T, Kuwana M
Expert Rev Respir Med
. 2024 Jun;
18(6):447-456.
PMID: 38943279
Background: Clinical guidance on the identification and management of connective tissue disease-associated interstitial lung disease (CTD-ILD) is needed for optimal clinical practice. We aimed to develop clinical algorithms for identifying...
8.
Bando M, Homma S, Date H, Kishi K, Yamauchi H, Sakamoto S, et al.
Respir Investig
. 2024 Mar;
62(3):402-418.
PMID: 38484504
Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease with a poor prognosis and an unknown cause that generally progresses to pulmonary fibrosis and leads to irreversible tissue alteration. The...
9.
Kurosaki F, Kuroki T, Nomura Y, Numao T, Bando M, Maemondo M
J Infect Chemother
. 2023 Nov;
30(4):357-361.
PMID: 37922986
Tuberculous meningitis (TBM) is a rare disease in low-incidence countries like Japan, where general physicians have fewer experience with TBM. Despite its proper treatment and early improvement of the condition,...
10.
Sada K, Nagasaka K, Kaname S, Nango E, Kishibe K, Dobashi H, et al.
Mod Rheumatol
. 2023 Aug;
34(3):559-567.
PMID: 37599461
Objective: To revise the 2017 clinical practice guidelines (CPG) for the management of microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA) to reflect advancements in the field. Methods: Similar to...